Plasma volume and especially plasma volume excess is a relevant predictor for the clinical
outcome of heart failure patients. In recent years, estimated plasma volume based on …

Aims Plasma volume (PV) expansion hallmarks worsening chronic heart failure (CHF) but
no non‐invasive means of quantifying volume status exists. Because weight and …

Background Calculated estimates of plasma volume (PV) have been developed with the use
of hemoglobin/hematocrit-body weight–based methods. The accuracy of such formula …

Aims Plasma volume expansion is clinically and prognostically relevant in individuals with
heart failure. Prior cohorts either excluded or had limited representation of patients with …

Background Progressive plasma volume (PV) expansion is a hallmark of chronic heart
failure (HF), ultimately contributing to decompensated heart failure. Monitoring PV might …

Plasma volume, estimated by several indirect methods, has been viewed as a biological
surrogate for intravascular fluid status. The clinical implication of estimated plasma volume …

Background: Congestion is one of the main predictors of poor outcome in patients with heart
failure (HF); thus, a simple tool to evaluate plasma volume (PV), which can be used for risk …

Background Prior analyses suggest an association between formula-based plasma volume
(PV) estimates and outcomes in heart failure (HF). We assessed the association between …

Assessing congestion is challenging but important to patients with chronic heart failure
(CHF). However, there are limited data regarding the association between estimated plasma …

Background: Plasma volume (PV) expansion hallmarks the syndrome of heart failure (HF)
but is difficult to be quantified noninvasively. Estimated plasma volume status (ePVS) has …